REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Metagone Biotech Inc. (Taiwan, China)

Main Activities: Medicinal and Botanical Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Metagone Biotech Inc. Profile Updated: March 30, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Metagone Biotech Inc. is based in Taiwan, China. The head office is in Taipei City. It operates in the Medicinal and Botanical Manufacturing sector. The enterprise was incorporated on January 22, 2015. 16 (2023) employees currently work for Metagone Biotech Inc.. Its’ total assets recorded a negative growth of 8.37%.

Headquarters
No. 13 3F, 3F, No. 11, Lane 77, Xing'Ai Rd.
Taipei City; Taipei City; Postal Code: 114067

Contact Details: Purchase the Metagone Biotech Inc. report to view the information.

Website: http://www.metagone.com.tw

Basic Information
Total Employees:
Purchase the Metagone Biotech Inc. report to view the information.
Outstanding Shares:
Purchase the Metagone Biotech Inc. report to view the information.
Financial Auditors:
Purchase the Metagone Biotech Inc. report to view the information.
Incorporation Date:
January 22, 2015
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
7.09%
Purchase this report to view the information.
4.84%
Purchase this report to view the information.
1.87%
Purchase this report to view the information.
1.46%
Purchase this report to view the information.
1.35%
Subsidiaries
Metagone Biotech Australia Pty.,Ltd. (Australia)
100%
Company Performance
Financial values in the chart are available after Metagone Biotech Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Total Operating Revenue
-69.6%▼
Operating Profit
-24.5%▼
EBITDA
-28.56%▼
Net Profit/Loss for the Period
-17.24%▼
Total Assets
-8.37%▼
Total Equity
-12.25%▼
Return on Equity (ROE)
-17.93%▼
Debt / Equity
-1016%▼
Quick Ratio
-339.66%▼
Cash Ratio
-0.38%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo